From 2022 to 2024, stimulant prescriptions issued in Connecticut increased by 13.2 percent, according to data from the state.

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...

WASHINGTON — The Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings ...

The FDA’s new warning for stimulants used to treat ADHD cites the drugs’ high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction.

Approximately 3.5 million children in the USA, ages 3-17, take attention-deficit/hyperactivity disorder (ADHD) medications, most commonly stimulants. These include ...

MONDAY, June 16, 2025 (HealthDay News) — People with ADHD might be prescribed their meds remotely without increasing their risk of addiction, a new study says. Experts have worried that prescribing ...

Attention Deficit/Hyperactivity Disorder (ADHD) is one of the most prevalent neurodevelopmental disorders and can persist into adulthood in the majority of cases. ADHD is associated with deficits in ...

May 13 (UPI) --ADHD stimulant meds don't increase children's risk of psychosis, a new study says. Analyses of stimulant prescriptions among nearly 8,400 kids with attention deficit/hyperactivity ...

The combination of prescribed central nervous system stimulants, such as drugs that relieve ADHD symptoms, with prescribed opioid medications is associated with a pattern of escalating opioid intake, ...

What attention-deficit hyperactivity disorder (ADHD) treatment alternatives are available for a child who has an adverse reaction to stimulants? Atomoxetine (Strattera) has been ineffective. —Janine ...

As of 1 February 2026, changes to New Zealand's prescribing rules for Attention-Deficit Hyperactivity Disorder (ADHD) ...